In October, Otsuka announced positive interim results from the Phase 3 sibeprenlimab trial. The ongoing Phase 3 study continues in a blinded manner to evaluate the change in kidney function over 24 ...
Dr Couchman says UTIs can also occur in babies and young children and with recurrent infections, the risk of kidney damage is vastly increased with the presence of reflux – where urine flows back from ...
The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) on Monday approved the medicine Filspari (sparsentan) from Vifor France to treat primary immunoglobulin A nephropathy (IgAN).
Germany’s defense minister said Tuesday officials have to assume damage to two data cables under the Baltic Sea, one of which ends in Germany, was caused by sabotage — though ...